<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <title>Obesity Template</title>
    <meta name="author" content="doakey3">
    
    <link rel="icon" type="image/svg+xml" href="favicon.svg">
    <meta name="author" content="doakey3"> 
    <meta name="description" content="A template for charting on obesity">
    <meta name="keywords" content="obesity, template, fat, overweight, bmi, weight, loss">
    
    <link rel="stylesheet" href="css/grow_wrap.css">
    <link rel="stylesheet" href="css/style.css">

</head>

<body>
<h1>Obesity Template</h1>
<div class="grow-wrap">
<textarea class="checkable resizable" spellcheck="false" autocomplete="off">
Indications for Pharmacologic Therapy of Obesity:
(    ) BMI &gt;= 30
(    ) BMI &gt;= 27 with comorbid conditions

Obesity-related Comorbid Conditions:
(    ) Diabetes mellitus
(    ) Dyslipidemia
(    ) Hypertension
(    ) Heart disease
(    ) Sleep apnea
(    ) Symptomatic Osteoarthritis

Common Medications that cause weight gain ("X" = patient is currently taking this medication):
(    ) Monoamine oxidase inhibitor
(    ) Tricyclic antidepressants (Eg: nortriptyline, amitriptyline, doxepin)
(    ) Paroxetine
(    ) Citalopram
(    ) Escitalopram
(    ) Imipramine
(    ) Mirtazepine
(    ) Thioridazine
(    ) Olanzapine
(    ) Risperidone
(    ) Clozapine
(    ) Quetiapine
(    ) Insulin
(    ) Sulfonylurea (Eg: glipizide, glyburide, glimepiride)
(    ) Glucocorticoids (Eg: prednisone)
(    ) Hormonals (especially progestins)
(    ) Anticonvulsants (Eg Divalproex)
(    ) Lithium
(    ) Carbamazepine
(    ) Gabapentin
(    ) Valproate
(    ) Cyproheptadine
(    ) Alpha blockers (especially terazosin)
(    ) Beta blockers (especially propranolol)

Contraindications for Phentermine:
(    ) Patient &lt; 18 years old
(    ) Heart disease
(    ) Uncontrolled hypertension
(    ) Women who are pregnant, nursing, or planning to become pregnant
(    ) Uncontrolled hyperthyroidism
(    ) Use of an MAOI in the last 14 days
(    ) Prone to agitation/anxiety (extreme restlessness and irritability)
(    ) History of drug abuse

Contraindications for Qsymia:
(    ) Patient &lt; 18 years old
(    ) Glaucoma
(    ) Uncontrolled hyperthyroidism
(    ) Use of MAOI in the last 14 days
(    ) History of kidney stones
(    ) Excessive alcohol use (would not be able to stop alcohol easily)
(    ) Cardiac arrhythmias or coronary artery disease
(    ) Anxiety

Contraindications for Contrave:
(    ) Patient is &lt; 18 years old
(    ) Women who are pregnant, nursing, or planning to become pregnant
(    ) Uncontrolled hypertension
(    ) History of seizure disorder
(    ) Eating disorder (bulimia, anorexia)
(    ) Glaucoma
(    ) Already taking buproprion
(    ) Use of MAOI in the last 14 days
(    ) Abrupt discontinuation of alcohol
(    ) Use of antiseizure, benzodiazepines, barbiturates, opiates

Contraindications for Orlistat:
(    ) Younger than 12 years old
(    ) Women who are pregnant, nursing, or planning to become pregnant
(    ) Chronic malabsorption syndrome (IBD, bowel resection)
(    ) History of gallstones
(    ) Use of cyclosporine, levothyroxine, warfarin, amiodarone, anti-seizure meds, antiretroviral drugs

Contraindications for Semaglutide:
(    ) Less than 18 years old
(    ) History of medullary thyroid cancer
(    ) History of multiple endocrine neoplasia syndrome type 2
(    ) Women who are pregnant, nursing, or planning to become pregnant

- avoid all caloric beverages (such as sodas) and processed foods
- engage in 30 minutes or more, five to seven days a week. Exercise is a strong predictor of weight loss maintenance.
- referral to nutritional medicine, patient should contact referral management to setup an appointment to discuss dietary methods for weight loss
- referral to behavioral health, patient should contact referral management to setup an appointment to discuss behavioral methods for weight loss
    - weigh self regularly
    - meal planning and tracking calories
    - slower eating
    - SMART goal setting (Specific, Measurable, Achievable, Relevant, Time-bound)
    - positive self-talk
    - identifying triggers for eating (restaurants, parties)
- patient to follow up for face to face appointment in 6 weeks for weight check, BP check, and heart rate check
- for diabetic patients, the patient should monitor glucose levels at least daily to watch for hypoglycemia
- note that medications for weight loss require a prior authorization (approval from Tricare), call the pharmacy 5 days after the prescription was written to see if it is available for pickup

OPTION 1: Phentermine
- start phentermine 37.5 mg tablet by mouth daily taken 1-2 hours after breakfast 
    - only a 30-day supply at a time is allowed
    - first-time use is limited to 90 days, not FDA approved for long-term use
    - patient should have weight &amp; blood pressure checked at least monthly during the first 3 months of use
- PMP aware checked, no evidence of prescription drug abuse
- common side effects may include dry mouth, restlessness, difficulty sleeping, increased heart rate, increased blood pressure
- avoid alcohol while using phentermine (alcohol worsens side effects of the medication)
- do not drive a car or operate heavy machinery until you know how phentermine affects you
- if weight loss is &lt; 5% after 12 weeks, will discontinue phentermine

OPTION 2: Phentermine-Topiramate (Qsymia)
- a pregnancy test must be negative prior to starting Qsymia
- PMP aware checked, no evidence of prescription drug abuse
- start Qsymia 3.75 mg/23 mg, 1 tablet by mouth every morning x 14 days
- (Day 15 and on) start Qsymia 7.5 mg/46 mg, 1 tablet by mouth daily thereafter
- common side effects may include numbness/tingling of hands/arms/feet/face, lightheadedness, trouble sleeping, constipation, dry mouth, trouble concentrating
- if you become pregnant while taking Qsymia, report it to your doctor and stop taking Qsymia immediately (high risk of birth defects)
- avoid drinking alcohol while taking Qsymia
- do not drive a car or operate heavy machinery until you know how Qsymia affects you
- if weight loss at 12 weeks &lt; 3%, will taper off Qsymia (every other day dosing x 1 week, then stop)

OPTION 3: Naltrexone-Bupropion (Contrave)
- start Contrave, tablet by mouth
- WEEK 1: one tablet daily
- WEEK 2: one tablet twice daily
- WEEK 3: two tablets in the morning, one tablet in the evening
- WEEK 4 and on: two tablets twice daily
- common side effects may include nausea, lightheadedness, loss of taste, trouble sleeping, constipation or diarrhea, headache, dry mouth
- Do not take Contrave with a fatty meal.
- Do not cut, chew, or crush Contrave, swallow it whole.
- If you miss a dose of Contrave, wait until your next regular time to take it.
- If weight loss after 12 weeks is &lt; 6%, will discontinue Contrave

OPTION 4: Orlistat (Xenical)
(NOTE: The medical necessity form for this medication is flawed, you have to pencil in why they can't use Contrave or they will deny it)
- start orlistat 120 mg by mouth three times daily with food
- start multivitamin by mouth daily, taken at least 2 hours before or after using orlistat
- common side effects include oily stool and stool spotting, gas and anal leakage, bowel urgency
- the higher the fat content of meals, the worse the side effects will be
- if weight loss after 12 weeks &lt; 6%, will discontinue orlistat 

OPTION 5: Semaglutide (Wegovy)
- start semaglutide weekly injection
- WEEKS 1-4: 0.25 mg injection weekly
- WEEKS 5-8: 0.5 mg injection weekly
- WEEKS 9-12: 1 mg injection weekly
- WEEKS 13-16: 1.7 mg injection weekly
- WEEKS 17 and on: 2.4 mg injection weekly
- rotate injection site weekly (abdomen, thigh, or upper arm)
- common side effects include abdominal pain, nausea, diarrhea, constipation, headache
- if weight loss after 12 weeks &lt; 6%, will discontinue semaglutide
</textarea>
</div>

<div id="notes">
<p>To prescribe Qsymia, you'll need to get certified at <a href="https://www.qsymiarems.com/">https://www.qsymiarems.com/</a></p>
    <figure>
    <center>
        <img src="media/comparing_drugs.gif">
        <figcaption>Average weight loss % after 52 weeks</figcaption>
    </center>
</figure>
</div>

<div id="references">
    <h2>References</h2>
    <ul>
        <li>AACE Phentermine Patient Information. <a href="https://pro.aace.com/files/obesity/toolkit/phentermine_patient_info.pdf">https://pro.aace.com/files/obesity/toolkit/phentermine_patient_info.pdf</a></li>
        <li>AACE Qsymia Management Checklist. <a href="https://qsymia.com/hcp/include/media/pdf/dosing-titration.pdf">https://qsymia.com/hcp/include/media/pdf/dosing-titration.pdf</a></li>
        <li>AACE Qsymia Patient Information. <a href="https://pro.aace.com/files/obesity/toolkit/qsymia_patient_info.pdf">https://pro.aace.com/files/obesity/toolkit/qsymia_patient_info.pdf</a></li>
        <li>AACE Contrave Patient Information. <a href="https://pro.aace.com/files/obesity/toolkit/contrave_patient_info.pdf">https://pro.aace.com/files/obesity/toolkit/contrave_patient_info.pdf</a></li>
        <li>AACE Xenical Patient Information. <a href="https://pro.aace.com/files/obesity/toolkit/xenical_patient_info.pdf">https://pro.aace.com/files/obesity/toolkit/xenical_patient_info.pdf</a></li>
        <li>Uptodate: "Obesity in adults: Overview of management". <a href="https://www.uptodate.com/contents/obesity-in-adults-overview-of-management">https://www.uptodate.com/contents/obesity-in-adults-overview-of-management</a></li>
        <li>Uptodate: "Obesity in adults: Drug therapy". The weight loss graph above is found on this site. <a href="https://www.uptodate.com/contents/obesity-in-adults-drug-therapy">https://www.uptodate.com/contents/obesity-in-adults-drug-therapy</a></li>
        <li>Uptodate Drug Information Page: Semaglutide. <a href="https://www.uptodate.com/contents/semaglutide-drug-information?search=semaglutide&source=panel_search_result&selectedTitle=1~26&usage_type=panel&kp_tab=drug_general&display_rank=1">Semaglutide: Drug Information</a></li>
        <li>Uptodate: "Obesity in adults: Behavioral therapy". <a href="https://www.uptodate.com/contents/obesity-in-adults-behavioral-therapy">https://www.uptodate.com/contents/obesity-in-adults-behavioral-therapy</a></li>
        <li>Note: The order of the options for pharmacologic therapy in this template were adapted to fit TRICARE's requirements. The prior authorization forms for each of the medications in this template can be found on the <a href="https://www.express-scripts.com/frontend/open-enrollment/tricare/fst#/formularyPricing/results">Tricare Express Scripts</a> website.
    </ul>
</div>

<div id="disclaimer">
    <p>This page was last updated on <span class="last_updated"></span></p>
    <p><b>Disclaimer</b>: Information presented in the template should be re-checked and should not be used alone to guide patient care or substitute for clinical judgement.</p>
    <p><b>Note</b>: Please copy text into the EMR prior to adding any HIPPA information. Though no information is being saved/transmitted on this site, typing private information into a web page is generally bad practice.</p>
</div>

</body>

<script src="js/setup_resizables.js"></script>
<script src="js/setup_boxes.js"></script>
<script>
    var textarea = document.getElementsByClassName("checkable")[0];
    textarea.focus();
</script>
<script>
    last_updateds = document.getElementsByClassName("last_updated");
    for (var i = 0; i < last_updateds.length; i++) {
        var mydate = new Date(document.lastModified);
        var newdate = new Intl.DateTimeFormat("en-US", {year: "numeric", month: "long", day: "numeric"}).format(mydate).replace(/\./g, '-');
        last_updateds[i].innerHTML = newdate;
    } 
</script>
</html>
